(NP (NP (JJ Multifactor) (JJ cis-dominant) (JJ negative) (NN regulation)) (PP (IN of) (NP (NN IL-2) (NN gene) (NN expression))) (PP (IN in) (NP (VBN anergized) (NN T) (NNS cells))) (. .))
(S (NP-SBJ-10 (NP (DT The) (JJ molecular) (NN mechanism)) (VP (VBG underlying) (NP (NP (NN IL-2) (JJ transcriptional) (NN blockade)) (PP (IN in) (NP (JJ anergic) (NN T) (NN cell) (NNS clones)))))) (VP (VBZ is) (RB not) (ADVP (RB fully)) (VP (VBN understood) (NP (-NONE- *-10)))) (. .))
(S (S (NP-SBJ (-NONE- *-11)) (VP (TO To) (VP (VB examine) (SBAR (IN whether) (S (NP-SBJ (DT an) (JJ active) (ADJP (JJ negative) (JJ regulatory)) (NN process)) (VP (VBZ occurs))))))) (, ,) (NP-SBJ-11 (PRP we)) (VP (VBD created) (NP (NP (DT a) (NN reporter) (NN construct)) (VP (VBG containing) (PP (IN as) (NP (DT an) (NN enhancer))) (NP (NP-COOD (NP (NP (CD four) (NNS copies)) (PP (IN of) (NP (DT the) (NN NF-AT) (NN site)))) (CC and) (NP (NP (CD one) (NN copy)) (PP (IN of) (NP (DT the) (NN octamer) (NN site))))) (PRN (-LRB- -LRB-) (NP (NN 4X) (NN NF-AT-Oct)) (-RRB- -RRB-)))))) (. .))
(S (NP-SBJ-12 (DT This) (NN construct)) (VP (VBD was) (ADVP (ADVP (RB only) (RB slightly)) (PRN (-NONE- *ICH*-101))) (VP (VBN reduced) (NP-13 (-NONE- *-12)) (PRN-101 (-LRB- -LRB-) (ADVP (RB 1.3-fold)) (-RRB- -RRB-)) (PP (IN in) (NP (PRP$ its) (NN expression))) (SBAR-TMP (WHADVP-15 (WRB when)) (S (NP-SBJ-14 (-NONE- *-13)) (VP (VBN stimulated) (NP (-NONE- *-14)) (PP (IN under) (NP (JJ anergic) (NNS conditions))) (ADVP (-NONE- *T*-15))))) (, ,) (SBAR (IN while) (S (NP-SBJ (DT a) (JJ whole) (NN mouse) (NN IL-2) (NN enhancer) (NN construct)) (VP (VBD showed) (NP (NP (DT a) (NN reduction)) (PP (IN of) (NP (JJ 4.3-fold))))))))) (. .))
(S (S-COOD (S (NP-SBJ (NP (NN Addition)) (PP (IN of) (NP (DT the) (NP-COOD (NP (CD -176)) (TO to) (NP (CD -96))) (NN sequence))) (PP (TO to) (NP (DT the) (NN 4X) (NN NF-AT-Oct) (NN construct)))) (VP (VBD did) (RB not) (VP (VB impart) (NP (DT the) (NN ability) (S (NP-SBJ-102 (-NONE- *)) (VP (TO to) (VP (VB be) (VP (VBN affected) (NP (-NONE- *-102)) (PP (IN by) (NP-LGS (NN anergy))))))))))) (, ,) (CC but) (S (NP-SBJ (NP (NN addition)) (PP (IN of) (NP (DT the) (NP-COOD (NP (CD -236)) (TO to) (NP (CD -96))) (NN sequence)))) (VP (VBD did) (VP (-NONE- *?*))))) (, ,) (S (NP-SBJ (-NONE- *)) (VP (VBG demonstrating) (SBAR-COOD (SBAR (IN that) (S (NP-SBJ (NN anergy)) (VP (VBZ is) (NP-PRD (DT an) (JJ active) (JJ inhibitory) (NN process))))) (CC and) (SBAR (IN that) (S (NP-SBJ-17 (NP (JJR more)) (PP (IN than) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NP (DT the) (CD -150) (NN AP-1) (NN binding) (NN site)) (PRN (-LRB- -LRB-) (NP-COOD (NP (CD -152)) (TO to) (NP (CD -147))) (-RRB- -RRB-))))))) (VP (VBZ is) (VP (VBN required) (NP (-NONE- *-17)) (S (NP-SBJ (-NONE- *)) (VP (TO to) (VP (VB mediate) (NP (DT the) (NN effect)))))))))))) (. .))
(S (NP-SBJ (NP (JJ Mutational) (NNS studies)) (PP (IN of) (NP (DT the) (NP-COOD (NP (CD -236)) (TO to) (NP (CD -96))) (NN sequence)))) (VP (VBD indicated) (SBAR (IN that) (S (NP-SBJ (NP (DT the) (NN presence)) (PP (IN of) (NP-COOD (CC both) (NP (DT the) (NP (NP (CD -130) (JJ AP-1-like) (NN site)) (PRN (-LRB- -LRB-) (NP-COOD (NP (CD -187)) (TO to) (NP (CD -181))) (-RRB- -RRB-)))) (CC and) (NP (DT the) (CD -150) (JJ proximal) (NN AP-1) (NN site))))) (VP (VBD were) (ADJP-PRD (JJ necessary) (S (NP-SBJ (-NONE- *)) (VP (TO to) (VP (VB observe) (NP (NN anergy)))))))))) (. .))
(S (SBAR (IN Because) (S (NP-SBJ-18 (DT the) (CD -180) (NN site)) (VP (VBZ is) (RB not) (VP (VBN required) (NP (-NONE- *-18)) (PP (IN for) (NP (NN trans-activation))))))) (, ,) (NP-SBJ (NP (PRP it)) (S (-NONE- *EXP*-19))) (VP (VBD was) (ADJP-PRD (JJ possible)) (S-19 (NP-SBJ (-NONE- *)) (VP (TO to) (VP (VB confirm) (PP (IN by) (NP (NP (NN mutation)) (PP (IN in) (NP (DT the) (JJ normal) (NN mouse) (NN IL-2) (NN enhancer))))) (SBAR (IN that) (S (NP-SBJ (DT this) (NN site)) (VP (VBZ is) (ADJP-PRD (RB absolutely) (JJ essential) (PP (IN for) (NP (NN anergy) (NN induction))))))))))) (. .))
(S (NP-SBJ (NP (DT The) (JJS simplest) (NN model)) (SBAR (WHNP-20 (-NONE- 0)) (S (NP-SBJ (-NONE- *T*-20)) (VP (TO to) (VP (VB explain) (NP (DT these) (NNS results))))))) (VP (VBZ is) (SBAR-PRD (IN that) (S (NP-SBJ-21 (NN anergy)) (VP (VBZ is) (VP (VBN mediated) (NP (-NONE- *-21)) (PP (IN by) (NP-LGS (NP (DT a) (NN complex)) (PP (IN of) (NP (NP (JJ multiple) (NN transcription) (NNS factors)) (SBAR (WHNP-22 (WDT that)) (S (NP-SBJ (-NONE- *T*-22)) (VP (VBP exert) (NP (DT a) (JJ cis-acting) (JJ dominant) (JJ negative) (JJ regulatory) (NN effect)) (PP (IN on) (NP (NP (DT the) (NN trans-activation)) (PP (IN of) (NP (DT the) (NN IL-2) (NN gene))))))))))))))))) (. .))
